COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment

Abstract
Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associ